Root Financial Partners LLC Buys 1,593 Shares of Intuitive Surgical, Inc. $ISRG

Root Financial Partners LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 58.6% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,313 shares of the medical equipment provider’s stock after acquiring an additional 1,593 shares during the period. Root Financial Partners LLC’s holdings in Intuitive Surgical were worth $1,988,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Draper Asset Management LLC lifted its position in Intuitive Surgical by 41.9% in the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after acquiring an additional 1,485 shares in the last quarter. Deutsche Bank AG increased its holdings in Intuitive Surgical by 9.6% during the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock worth $862,108,000 after purchasing an additional 132,966 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Intuitive Surgical by 29.3% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock worth $40,255,000 after purchasing an additional 16,119 shares in the last quarter. Procyon Advisors LLC raised its stake in shares of Intuitive Surgical by 787.8% in the fourth quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock worth $2,715,000 after purchasing an additional 4,254 shares during the last quarter. Finally, Robinhood Asset Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $6,478,000. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock worth $3,059,135 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ISRG. Mizuho set a $525.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. TD Cowen lowered their price target on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. HSBC dropped their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Raymond James Financial reduced their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Finally, BTIG Research reissued a “buy” rating and set a $574.00 price target on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $573.42.

Intuitive Surgical Trading Up 1.2%

Shares of ISRG opened at $402.38 on Thursday. The stock has a 50 day moving average of $428.93 and a 200 day moving average of $480.82. The company has a market capitalization of $142.51 billion, a price-to-earnings ratio of 48.77, a PEG ratio of 3.24 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business’s revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.